Abstract LB-12: Plasma 25-hydroxyvitamin D levels are associated with aggressive prostate cancer among African Americans in the North Carolina-Louisiana Prostate Cancer Project (PCaP).
Anna Woloszynska‐Read(Roswell Park Comprehensive Cancer Center), Susan E. Steck(University of South Carolina), Jeannette T. Bensen(University of North Carolina at Chapel Hill), John S. Adams(University of California System), Fred K. Tabung(Harvard University), James L. Mohler, Candace S. Johnson(Roswell Park Comprehensive Cancer Center), Hongmei Zhang(China Medical University), Donald L. Trump(Inova Health System), Lenore Arab(University of California, Los Angeles), Joseph Su(The University of Texas Southwestern Medical Center), Elizabeth T. H. Fontham(Louisiana State University)
Cited by 0
Related Papers
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
|CA A Cancer Journal for Clinicians|2020|966
Prostate Cancer
|Journal of the National Comprehensive Cancer Network|2010|902
Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study
|Journal of Clinical Oncology|1999|893